WASHINGTON — In his first tackle to FDA workers on Wednesday, Vinay Prasad emphasised his dedication to proof, his admiration for company workers, and his want to serve the American public.
The new director of the Middle for Biologics Analysis and Analysis sounded very completely different from his on-line firebrand persona. He struck a humble, self-deprecating, and even earnest tone, calling the American folks the company’s “primary stakeholder.”
“My educational analysis self-discipline is epidemiology, evidence-based drugs,” Prasad mentioned in a recording obtained by STAT. “I applaud what you do. I’ve realized loads from studying your papers during the last 20 years.”
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
